madman
Super Moderator
"This is a phase 1 clinical trial, so we're primarily looking at safety and adverse events. We’ve had none in the 46 participants that we have so far," says David Alejandro Velasquez.
www.urologytimes.com
In this video, David Alejandro Velasquez, Ranjith Ramasamy, MD, and Manuel Leyba Molina, MD, highlight the background and preliminary findings from the study, “Safety and Feasibility of the COCKTAIL (Combining Shockwave Therapy and Platelet-Rich Plasma for Erectile Dysfunction) Trial: A Single Center, Randomized, Double-Blind, Sham-Controlled Study Update,” which will be presented at the 2023 SMSNA Annual Meeting in San Diego, California.
Experts highlight preliminary findings from the COCKTAIL trial in ED
"This is a phase 1 clinical trial, so we're primarily looking at safety and adverse events. We’ve had none in the 46 participants that we have so far," says David Alejandro Velasquez.
In this video, David Alejandro Velasquez, Ranjith Ramasamy, MD, and Manuel Leyba Molina, MD, highlight the background and preliminary findings from the study, “Safety and Feasibility of the COCKTAIL (Combining Shockwave Therapy and Platelet-Rich Plasma for Erectile Dysfunction) Trial: A Single Center, Randomized, Double-Blind, Sham-Controlled Study Update,” which will be presented at the 2023 SMSNA Annual Meeting in San Diego, California.
